Invention Grant
- Patent Title: Compounds
-
Application No.: US16639292Application Date: 2018-08-15
-
Publication No.: US11253499B2Publication Date: 2022-02-22
- Inventor: Esther Porras De Francisco , Modesto Jesús Remuiñan-Blanco , Marilyne Bourotte , Benoit Deprez , Geoffroy Dequirez , Nicolas Willand
- Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED , BIOVERSYS AG
- Applicant Address: GB Middlesex; CH Basel
- Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED,BIOVERSYS AG
- Current Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED,BIOVERSYS AG
- Current Assignee Address: GB Middlesex; CH Basel
- Agent Robert H. Brink; Scott Young; Duke M. Fitch
- Priority: EP17382571 20170816
- International Application: PCT/EP2018/072145 WO 20180815
- International Announcement: WO2019/034702 WO 20190221
- Main IPC: A61K31/397
- IPC: A61K31/397 ; A61P31/06 ; A61K31/4427 ; A61K45/06 ; C07D205/04 ; C07D401/04 ; C07D405/04
Abstract:
The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by Mycobacterium, such as tuberculosis.
Public/Granted literature
- US20200170997A1 NOVEL COMPOUNDS Public/Granted day:2020-06-04
Information query
